Anticandidal Therapeutics

Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Dr. Anubhuti Jha works in the area of antifungal drug discovery. She has obtained PhD degree from Department of Biotechnology, National Institute of Technology, Raipur (CG), India. She has published more than 15 research paper in peer_x0002_reviewed journals and has authored several books/chapters.

• 1. History of infection2. Brief introduction on infection3. Fungal diseases and antifungal drugs4. Multidrug transporters of fungal pathogen Candida5. Essential anticandidal targets6. Stages of anticandidal agent development7. Recent trends and progress in antifungal translational research8. Clinical status of anticandidal therapeutic agents9. Drug repurposing for development of effective anticandidals10. Commercial aspects of drug development11. Challenges and future prospects